| Novartis expects record benefit from the H1N1 vaccine sales |
| World - Business | |||
| Thursday, 22 October 2009 14:49 | |||
 Novartist's operative benefit for the first nine months of this year reveals 2,6 billion dollar.
This Swiss pharmacy company noticed growth of the benefit of 2,11 billion dollar in the third quarter this year.The sales also had a minimal raise up to 11,08 billion dollar. The company informs that they expect to reach record operative and net benefits this year, even if the financial contribution from the vaccines for the virus is not included. The operative benefit of the company for the first nine mounths of this year reveals 2,6 billion dollar, which presents 300 million dollar increase compared to last year.
|
